Cargando…

Cohort protocol paper: The Pain and Opioids In Treatment (POINT) study

BACKGROUND: Internationally, there is concern about the increased prescribing of pharmaceutical opioids for chronic non-cancer pain (CNCP). In part, this is related to limited knowledge about the long-term benefits and outcomes of opioid use for CNCP. There has also been increased injection of some...

Descripción completa

Detalles Bibliográficos
Autores principales:	Campbell, Gabrielle, Mattick, Richard, Bruno, Raimondo, Larance, Briony, Nielsen, Suzanne, Cohen, Milton, Lintzeris, Nicholas, Shand, Fiona, Hall, Wayne D, Hoban, Bianca, Kehler, Chyanne, Farrell, Michael, Degenhardt, Louisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4000138/ https://www.ncbi.nlm.nih.gov/pubmed/24646721 http://dx.doi.org/10.1186/2050-6511-15-17

Ejemplares similares

Pharmaceutical Opioid Use Patterns and Indicators of Extramedical Use and Harm in Adults With Chronic Noncancer Pain, 2012-2018
por: Degenhardt, Louisa, et al.
Publicado: (2021)

Risk factors for indicators of opioid-related harms amongst people living with chronic non-cancer pain: Findings from a 5-year prospective cohort study
por: Campbell, Gabrielle, et al.
Publicado: (2020)

Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: protocol for the CoLAB study
por: Larance, Briony, et al.
Publicado: (2020)

Perceptions of extended‐release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia
por: Larance, Briony, et al.
Publicado: (2020)

The POPPY Research Programme protocol: investigating opioid utilisation, costs and patterns of extramedical use in Australia
por: Degenhardt, Louisa, et al.
Publicado: (2015)

Opioid use and harms associated with a sustained-release tapentadol formulation: a postmarketing study protocol
por: Peacock, Amy, et al.
Publicado: (2018)

Examining the cost and impact of dosing fees among clients in opioid agonist treatment: Results from a cross‐sectional survey of Australian treatment clients
por: Zahra, Emma, et al.
Publicado: (2022)

A protocol for a discrete choice experiment: understanding patient medicine preferences for managing chronic non-cancer pain
por: Shanahan, Marian, et al.
Publicado: (2019)

Opioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studies
por: Nielsen, Suzanne, et al.
Publicado: (2022)

Using routinely collected data to understand and predict adverse outcomes in opioid agonist treatment: Protocol for the Opioid Agonist Treatment Safety (OATS) Study
por: Larney, Sarah, et al.
Publicado: (2018)

Take-Home Naloxone for the Emergency Interim Management of Opioid Overdose: The Public Health Application of an Emergency Medicine
por: Strang, John, et al.
Publicado: (2019)

The effect of opioid analgesics, benzodiazepines, gabapentinoids, and opioid agonist treatment on mortality risk among opioid-dependent people.
por: Bharat, Chrianna, et al.
Publicado: (2022)

Combating escalating harms associated with pharmaceutical opioid use in Australia: the POPPY II study protocol
por: Gisev, Natasa, et al.
Publicado: (2018)

State-Level Prevalence and Associates of Opioid Dependence in the USA
por: Leung, Janni, et al.
Publicado: (2022)

The impact of opioid agonist treatment on fatal and non-fatal drug overdose among people with a history of opioid dependence in NSW, Australia, 2001-2018: findings from the OATS retrospective linkage study.
por: Jones, Nicola, et al.
Publicado: (2022)

The effect of entry and retention in opioid agonist treatment on contact with the criminal justice system among opioid-dependent people: a retrospective cohort study
por: Gisev, Natasa, et al.
Publicado: (2019)

Reducing the opioid overdose death toll in North America
por: Hall, Wayne D., et al.
Publicado: (2018)

Cohort profile: POPPY II – a population-based cohort examining the patterns and outcomes of prescription opioid use in New South Wales, Australia
por: Gisev, Natasa, et al.
Publicado: (2023)

The Impact of Stigma on People with Opioid Use Disorder, Opioid Treatment, and Policy
por: Cheetham, Ali, et al.
Publicado: (2022)

Opioid prescribing in Australia: too much and not enough
por: Dunlop, Adrian J, et al.
Publicado: (2021)

Opioid substitution therapy as a strategy to reduce deaths in prison: retrospective cohort study
por: Larney, Sarah, et al.
Publicado: (2014)

Managing opioid withdrawal precipitated by buprenorphine with buprenorphine
por: Oakley, Bridget, et al.
Publicado: (2021)

Mood and Anxiety Symptoms in Persons Taking Prescription Opioids: A Systematic Review with Meta-Analyses of Longitudinal Studies
por: Leung, Janni, et al.
Publicado: (2022)

Recommendations for the Prevention, Detection, Treatment and Management of Prescription Opioid Analgesic Dependence: Outcomes From the Opioid Analgesic Dependence Education Nexus (OPEN) Meeting
por: Kraus, Mark, et al.
Publicado: (2015)

The impact of changes to heroin supply on blood-borne virus notifications and injecting related harms in New South Wales, Australia
por: Day, Carolyn, et al.
Publicado: (2005)

Using intervention time series analyses to assess the effects of imperfectly identifiable natural events: a general method and example
por: Gilmour, Stuart, et al.
Publicado: (2006)

The "lessons" of the Australian "heroin shortage"
por: Degenhardt, Louisa, et al.
Publicado: (2006)

Systematic review of guidelines for managing physical health during treatment for substance use disorders: Implications for the alcohol and other drug workforce
por: Osborne, Briony, et al.
Publicado: (2022)

Five-Year Trajectories of Prescription Opioid Use
por: Gisev, Natasa, et al.
Publicado: (2023)

“Frustrated with the whole system”: a qualitative framework analysis of the issues faced by people accessing health services for chronic pain
por: Hopkins, Ria E., et al.
Publicado: (2022)

Strategies for Transfer From Methadone to Buprenorphine for Treatment of Opioid Use Disorders and Associated Outcomes: A Systematic Review
por: Lintzeris, Nicholas, et al.
Publicado: (2022)

Was an increase in cocaine use among injecting drug users in New South Wales, Australia, accompanied by an increase in violent crime?
por: Degenhardt, Louisa, et al.
Publicado: (2005)

“You'll come in and dose even in a global pandemic”: A qualitative study of adaptive opioid agonist treatment provision during the COVID-19 pandemic
por: Conway, Anna, et al.
Publicado: (2023)

Identifying Prescription-Opioid-Related Risks Using Prescription Drug Monitoring Programs’ Algorithms and Clinical Screening Tools
por: Picco, Louisa, et al.
Publicado: (2023)

Opioid agonist treatment and risk of death or rehospitalization following injection drug use–associated bacterial and fungal infections: A cohort study in New South Wales, Australia
por: Brothers, Thomas D., et al.
Publicado: (2022)

Modeling the population‐level impact of opioid agonist treatment on mortality among people accessing treatment between 2001 and 2020 in New South Wales, Australia
por: Chaillon, Antoine, et al.
Publicado: (2021)

Should Burden of Disease Estimates Include Cannabis Use as a Risk Factor for Psychosis?
por: Degenhardt, Louisa, et al.
Publicado: (2009)

Naloxone for opioid toxicity and overdose in the community
por: Jauncey, Marianne, et al.
Publicado: (2021)

Age at first alcohol‐related hospital separation or emergency department presentation and rate of re‐admission: A retrospective data linkage cohort of young Australians
por: Yuen, Wing S., et al.
Publicado: (2022)

Offending, custody and opioid substitution therapy treatment utilisation among opioid-dependent people in contact with the criminal justice system: comparison of Indigenous and non-Indigenous Australians
por: Gisev, Natasa, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_5o0rsm13ehbjr1sj8vduolodun